PTK2 and cancer: Focal adhesion kinase (FAK) promoted the aerobic glycolysis of cancer cells and fibroblasts, while FAK-related non-kinase kinase (FRNK) inhibited the aerobic glycolysis of HSC by inhibiting the FAK/Ras/c-MYC/ENO1 pathway, thereby improving liver fibrosis.